Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2003 07:25 ET | Source: BioXell SpA

BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia

MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound,...
January 08, 2003 04:52 ET | Source: BioXell SpA

BioXell Appoints Alex Martin as Chief Business Officer

MILAN, Italy, Jan. 8, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Alex Martin as Chief Business Officer. Mr Martin...
September 09, 2002 04:47 ET | Source: BioXell SpA

BioXell Announces an Exclusive Collaboration with TaiGen

MILAN, Italy, Sept. 9, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced an exclusive joint collaboration agreement with TaiGen...
July 18, 2002 06:13 ET | Source: BioXell SpA

BioXell Listed by Tornado Insider as One of Europe's Top 100 Start-Ups

MILAN, Italy, July 18, 2002 (PRIMEZONE) -- July 2002 BioXell S.p.A. was recently named in the second annual "Tornado Insider 100" list as one of Europe's top emerging private tech companies. BioXell,...
July 02, 2002 07:20 ET | Source: BioXell SpA

BioXell Appoints Dr. Bernd Seizinger to Board of Directors

MILAN, Italy, July 2, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Professor Bernd Seizinger to the Board of...
June 26, 2002 06:17 ET | Source: BioXell SpA

BioXell Announces the Discovery of a Receptor Implicated in the Development of Chronic Obstructive Pulmonary Disease

MILAN, Italy, June 26, 2002 (PRIMEZONE) -- BioXell SpA today announced the publication of a study in the May issue of The American Journal of Respiratory and Critical Care Medicine on the...
June 06, 2002 06:23 ET | Source: BioXell SpA

BioXell Announces the Formation of its Scientific Advisory Board

MILAN, Italy, June 6, 2002 (PRIMEZONE) -- BioXell SpA, the recently-formed Italian biopharmaceutical company focused on immunology, today announced the formation of its Scientific Advisory Board. The...
April 26, 2002 07:27 ET | Source: BioXell SpA

BioXell SpA: Vitamin D3 Analogue Arrests the Development of Autoimmune Diabetes

MILANO, Italy, April 26, 2002 (PRIMEZONE) -- BioXell SpA announced today the publication of a study in the May issue of the journal Diabetes describing the ability of a synthetic analogue of the...
March 26, 2002 07:56 ET | Source: BioXell SpA

BioXell: New Immunology Company Launched; Roche Spin-Out Raises Euro 22 Million from International Investors

MILAN, Italy, March 26, 2002 (PRIMEZONE) -- BioXell SpA announced its official launch today at a press conference in Milan. The firm combines extensive industry experience with a competitive edge in...